Folium Biosciences operates as a vertically integrated producer, manufacturer and distributor of hemp-derived phytocannabinoids and owns the largest phytocannabinoid extraction and purification facility in the United States. The company supplies 0.0% THC phytocannabinoid-rich hemp oil produced via a chromatographic purification process that selectively removes the psychoactive component. Folium is certified by the Colorado Department of Public Health and Environment to produce 0.0% THC products and offers a broad product set including CBD hemp oil, gel caps, water-soluble CBD, e-liquid, concentrates, pet products, salves, tinctures, face masks and white-label items. Management has signaled growth expectations following the 2018 Farm Bill and is planning a new pharmaceutical division and completion of a Canadian facility in 2019. The company reported a $3 million investment from Australis Capital as part of a private placement announced in January 2019.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2019